AdvanDx

About:

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

Website: http://www.advandx.com

Twitter/X: advandx

Top Investors: bioMerieux, Merck Global Health Innovation Fund, SLS Venture, LD Pensions

Description:

AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for the identification of pathogens causing critical infections in hospitalized patients. Its mission is to help healthcare providers optimize antibiotic therapy earlier in order to improve patient outcomes while limiting unnecessary antibiotic use and reducing hospital costs. AdvanDx was founded in 2002 and headquartered in Woburn, Massachusetts.

Total Funding Amount:

$49.7M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

2002-01-01

Contact Email:

usa(AT)advandx.com

Founders:

Henrik Stender

Number of Employees:

11-50

Last Funding Date:

2015-03-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai